Insuling costs are rising – and diabetic Americans of color are hit hardest | Mona Chalabi squib

Black, Hispanic and Asian adults are much more likely to have diabetes than white adults – and they’re less likely to be insured

The pharmaceutical industry is the single most profitable slice of the American economy. Deregulation and a greed for profits have driven companies to hike up the prices for insulin, an essential drug taken by more than 7 million diabetic Americans.

Related: The Memphis hospital suing its own workers for unpaid medical bills

Continue reading...
Scroll for more
Continue reading on The Guardian...